Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
WOODCLIFF LAKE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will participate in a panel presentation at the Cantor Global Healthcare Conference 2023 as follows:
To schedule a 1x1 meeting with management, please contact [email protected].
The webcast of the presentation will be accessible for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors section.
Investor Relations for Eagle Pharmaceuticals, Inc.:
Public Relations for Eagle Pharmaceuticals, Inc.: